Use before injection, in order to clean the skin, kill germs, avoid infection.
Against virus and killing germ for 6 hours.
Applicable for skin, medical instrument, antiseptic.
Clean ,safety and comfortable and convenient to use.
Suitable for cleaning the wounds and injection disinfection.
For professional and hospital use.
Packing: PE bag.
Povidone Iodine Swab, The COVID-19 pandemic has raised concerns of inadvertent SARS-CoV-2 transmission to healthcare workers during routine procedures of the aerodigestive tract in asymptomatic COVID-19 patients. Current efforts to mitigate this risk focus on Personal Protective Equipment, including high-efficiency filtration as well as other measures.
Povidone Iodine Swab
Because the reservoir for SARS-CoV-2 shedding is in the nasopharynx and nasal and oral cavities, the application of viricidal agents to these surfaces may reduce the virus burden. Numerous studies have confirmed that povidone-iodine inactivates many common respiratory viruses, Povidone Iodine Swab including SARS-CoV-1. Povidone-iodine also has a good profile for mucosal tolerance. Thus, we propose a prophylactic treatment protocol for the application of topical povidone-iodine to the upper aerodigestive tract.
Such an approach represents a low-cost, low-morbidity measure that may reduce the risks associated with aerosol-generating procedures performed commonly in otorhinolaryngology operating rooms.
The COVID-19 pandemic has increased awareness of operating room transmission risks of the responsible virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 can remain aerosolized for at least three hours under experimental conditions and may persist for greater than 72 h on plastic and stainless steel surfaces; this creates substantial risks to all healthcare professionals. The virus may reside in high concentrations in the nasal cavity, nasopharynx, oral cavity, and oropharynx, and thus opportunities for dissemination of SARS-CoV-2 in the operating suite have been hypothesized. Intubation, as well as transoral and transnasal procedures, may pose a unique risk as viral particles may be aerosolized while performing these measures, and contact with mucosa can be extensive. Various anecdotes confirm a relatively high prevalence of COVID-19 among otorhinolaryngologists, and for this reason, special precautions have been proposed for many aerosol-generating transnasal procedures. Given that a minority of infected patients may remain asymptomatic, and that rapid and reliable screening remains limited, prevention against viral exposure has primarily focused on Personal Protective Equipment (PPE) Topical oronasal treatment with povidone-iodine (PVP-I), better known as Betadine™ (Avrio Health, LP), maybe an effective method to immediately reduce the viral load of the upper aerodigestive tract and thus decrease the risk of inadvertent virus transmission.